MEREO BIOPHARMA GROUP PLC

Insiders Mereo BioPharma Group plc London S.E.

Equities

MPH

GB00BZ4G2K23

Delayed London S.E. Other stock markets			5-day change	1st Jan Change
- ^GBX	-.--%		-10.17%	-.--%

05-10	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT
05-03	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mereo BioPharma Group plc Announces Board Changes	28/10/22	CI
Mereo BioPharma Group plc Announces Board Changes	17/05/22	CI
Mereo BioPharma Group plc Announces Appointment of Anne Hyland to Board of Directors	01/03/22	CI
Mereo Biopharma Announces Board Changes	20/09/21	CI
Mereo Biopharma Group plc Announces the Appointment of Suba Krishnan, M.D. as Senior Vice President of Clinical Development, Effective December 7, 2020	23/11/20	CI
Mereo Biopharma Group plc Appoints Heidi Petersen as Senior Vice President, Regulatory Affairs	20/10/20	CI
Mereo BioPharma Group plc Announces Changes to Board of Directors	28/09/20	CI
Mereo Biopharma Group plc Appoints Michael Wyzga as Interim Chief Financial Officer	03/08/20	CI
Mereo Biopharma Group plc Cease Michael Wyzga as Member of Audit and Risk Committee	03/08/20	CI
Richard Jones Announces Step Down from the Board of Mereo BioPharma Group plc	30/06/20	CI
Mereo BioPharma Group plc Appoints John Lewicki, as Chief Scientific Officer and Ann Kapoun as SVP of Translational Research and Development	30/06/20	CI
Mereo BioPharma Group plc Appoints Arun Mistry as Therapeutic Area Head, Setrusumab	17/09/19	CI
Mereo BioPharma Group plc Appoints Richard Francis as Head of Pharmaceutical Development, Effective August 1, 2019	16/07/19	CI
Mereo BioPharma Group plc Announces Board Appointments	23/04/19	CI
Mereo Biopharma Group plc Announces Board Changes	11/02/19	CI
Mereo BioPharma Group plc Announces Board Appointments	05/12/18	CI
Mereo BioPharma Group plc Appoints Wills Hughes-Wilson as Head of Patient Access and Commercial Planning	26/02/18	CI
Mereo Biopharma Group plc Appoints Richard CM Jones as Chief Financial Officer and Board of Director	07/11/16	CI
Richard Bungay to Leave Mereo BioPharma Group plc as Chief Financial Officer and Chief Operating Officer in April 2017	05/10/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**Secure and Increase the Performance of your Investments with our Team of Experts at your Side**#ffffff**/registration/member/**#004eff**#000000**Securing my Investments**1**

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer